← Back to Search

Patients for Acid Reflux (SCREEN-BE Trial)

N/A
Waitlist Available
Led By Sachin Wani, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial is testing different ways of screening for Barrett's Esophagus to see which one is best at reducing the incidence of Esophageal Adenocarcinoma.

Eligible Conditions
  • Acid Reflux
  • Barrett's Esophagus
  • Esophageal Adenocarcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To characterize the association between patient-level knowledge, attitudes, and barriers regarding BE screening.
To define provider-level knowledge, attitudes, and barriers to BE screening.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Primary Care ProvidersExperimental Treatment1 Intervention
400 eligible primary care providers (PCPs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible PCPs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for providers to complete a paper survey at PCP clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.
Group II: PatientsExperimental Treatment1 Intervention
500 eligible patients will be recruited across the 7 participating sites to complete a survey. The survey will be distributed to eligible patients at the time of a clinic appointment, via telephone, or via a REDCap internet survey that will allow for 2 additional electronic phone call reminders and 1 email reminder.
Group III: GastroenterologistsExperimental Treatment1 Intervention
100 eligible gastroenterologists (GIs) will be recruited across the 7 participating sites to complete an anonymous survey. The survey will be distributed to eligible GIs by the study site research coordinator via anonymous REDCap internet survey with 2 additional automated electronic reminders. There will also be opportunities for GIs to complete a paper survey at provider clinic meetings which will be collected by only the site research coordinator to maintain response anonymity.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Survey
2014
N/A
~960

Find a Location

Who is running the clinical trial?

American College of GastroenterologyOTHER
37 Previous Clinical Trials
6,225 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,786 Previous Clinical Trials
2,786,883 Total Patients Enrolled
Sachin Wani, MDPrincipal InvestigatorUniversity of Colorado, Denver
8 Previous Clinical Trials
8,312 Total Patients Enrolled
~130 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top